Chiesi puts down $200M+ to col­lab­o­rate with Af­fi­body for res­pi­ra­to­ry dis­eases

The Ital­ian drug de­vel­op­er Chiesi will be look­ing to drop nine fig­ures to de­vel­op sev­er­al treat­ments for res­pi­ra­to­ry dis­eases in a deal with Swedish biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER